Definium Therapeutics develops psychedelic-based therapeutics for psychiatric and neurological disorders. Backed by North Carolina Biotechnology Center.
About the role
Together we are moving psychiatry forward—beyond better, into a boundless future. Join us! Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- Bachelor’s degree required, advanced degree (MBA, life sciences, education, or related) preferred
- Minimum 12 years of progressive experience in the pharmaceutical/biotech industry within the commercial function, including but not limited to, sales training, sales excellence, and or commercial capability development
- Experience in leading successful sales training initiatives, product launch initiatives, leadership development, curriculum design and training evaluation
- Deep understanding of adult learning principles, instructional design, and modern training delivery methods (live, virtual, e-learning, simulations, role-play, etc.)
- Experience in managing consultants and vendor relationships to ensure effective design and implementation of training solutions
- Strong scientific acumen and ability to translate complex clinical data into compelling, compliant field narratives
More about this role
Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.
Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq...
Browse similar: Startup jobs · Remote jobs